A systematic review of commercial hybrid closed-loop automated insulin delivery systems

S Peacock, I Frizelle, S Hussain - Diabetes Therapy, 2023 - Springer
Introduction Several different forms of automated insulin delivery systems (AID systems)
have recently been developed and are now licensed for type 1 diabetes (T1D). We …

Automated insulin delivery systems in children and adolescents with type 1 diabetes: a systematic review and meta-analysis of outpatient randomized controlled trials

B Zeng, L Gao, Q Yang, H Jia, F Sun - Diabetes Care, 2023 - diabetesjournals.org
BACKGROUND The glycemic control of automated insulin delivery (AID) systems in
outpatient children and adolescents with type 1 diabetes (T1D) has not been systematically …

[HTML][HTML] Trial of hybrid closed-loop control in young children with type 1 diabetes

RP Wadwa, ZW Reed, BA Buckingham… - … England Journal of …, 2023 - Mass Medical Soc
Background Closed-loop control systems of insulin delivery may improve glycemic
outcomes in young children with type 1 diabetes. The efficacy and safety of initiating a …

[HTML][HTML] Integrating metabolic expenditure information from wearable fitness sensors into an AI-augmented automated insulin delivery system: a randomised clinical …

PG Jacobs, N Resalat, W Hilts, GM Young… - The Lancet Digital …, 2023 - thelancet.com
Background Exercise can rapidly drop glucose in people with type 1 diabetes. Ubiquitous
wearable fitness sensors are not integrated into automated insulin delivery (AID) systems …

Positive impact of the bionic pancreas on diabetes control in youth 6–17 years old with type 1 diabetes: a multicenter randomized trial

Bionic Pancreas Research Group… - Diabetes technology …, 2022 - liebertpub.com
Objective: To evaluate the insulin-only configuration of the iLet® bionic pancreas (BP) in
youth 6–17 years old with type 1 diabetes (T1D). Research Design and Methods: In this …

Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review

LM Jacobsen, JL Sherr, E Considine, A Chen… - Communications …, 2023 - nature.com
Background The greatest change in the treatment of people living with type 1 diabetes in the
last decade has been the explosion of technology assisting in all aspects of diabetes …

Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled …

A Godoi, I Reis Marques, EMH Padrão… - Diabetology & Metabolic …, 2023 - Springer
Abstract Background Glycaemic control of Type 1 Diabetes Mellitus (T1DM) remains a
challenge due to hypoglycaemic episodes and the burden of insulin self-management …

[HTML][HTML] Telemedicine in improving glycemic control among children and adolescents with type 1 diabetes mellitus: systematic review and meta-analysis

K Zhang, Q Huang, Q Wang, C Li, Q Zheng, Z Li… - Journal of Medical …, 2024 - jmir.org
Background Type 1 diabetes mellitus (T1DM) is the most common chronic autoimmune
disease among children and adolescents. Telemedicine has been widely used in the field of …

Use of diabetes technology in children

MJ Schoelwer, MD DeBoer, MD Breton - Diabetologia, 2024 - Springer
Children with type 1 diabetes and their caregivers face numerous challenges navigating the
unpredictability of this complex disease. Although the burden of managing diabetes remains …

Effect of 48 months of closed-loop insulin delivery on residual C-peptide secretion and glycemic control in newly diagnosed youth with type 1 diabetes: a randomized …

J Ware, CK Boughton, JM Allen, ME Wilinska… - Diabetes …, 2024 - diabetesjournals.org
OBJECTIVE We evaluated the effect of long-term intensive metabolic control with hybrid
closed-loop (CL) on residual C-peptide secretion and glucose control compared with …